CSF hypocretin-1 levels are normal in multiple-system atrophy

Parkinsonism and Related Disorders

Volumn 14, Issue 4, 2008, Pages 342-344

  Abdo, W F ^a   Bloem, B R ^a   Kremer, H P H ^a   Lammers, G J ^b   Verbeek, M M ^a   Overeem, S ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CSF; Hypocretin; Multiple system atrophy; Orexin; Sleep disorders

Indexed keywords

OREXIN A;

ADULT; AGED; ARTICLE; CEREBELLUM DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROTRANSMISSION; PARKINSONISM; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SLEEP DISORDER;

AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROPEPTIDES;

EID: 44349117516     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.08.012     Document Type: Article

References (12)

1. Ghorayeb I., Yekhlef F., Chrysostome V., Balestre E., Bioulac B., and Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry 72 (2002) 798-800
2. Fronczek R., Overeem S., Lee S.Y., et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 130 (2007) 1577-1585
3. Thannickal T.C., Lai Y.Y., and Siegel J.M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130 (2007) 1586-1595
4. Drouot X., Moutereau S., Nguyen J.P., et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 61 (2003) 540-543
5. Yasui K., Inoue Y., Kanbayashi T., Nomura T., Kusumi M., and Nakashima K. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 250 (2006) 120-123
6. Litvan I., Bhatia K.P., Burn D.J., et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18 (2003) 467-486
7. Abdo W.F., van de Warrenburg B.P., Munneke M., et al. CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia. Neurology 67 (2006) 474-479
8. Mignot E., Lammers G.J., Ripley B., et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59 (2002) 1553-1562
9. Ripley B., Overeem S., Fujiki N., et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 57 (2001) 2253-2258
10. Baumann C., Ferini-Strambi L., Waldvogel D., Werth E., and Bassetti C.L. Parkinsonism with excessive daytime sleepiness-a narcolepsy-like disorder?. J Neurol 252 (2005) 139-145
11. Benarroch E.E., Schmeichel A.M., Sandroni P., Low P.A., and Parisi J.E. Involvement of hypocretin neurons in multiple system atrophy. Acta Neuropathol (Berlin) 113 (2007) 75-80
12. Gerashchenko D., Murillo-Rodriguez E., Lin L., et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184 (2003) 1010-1016